The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese Population

NCT00516971 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

200

Enrollment

OTHER_GOV

Sponsor class

Conditions

Gastroesophageal Reflux

Interventions

DRUG: Esomeprazole 20mg once daily

Sponsor

Hospital Authority, Hong Kong

Collaborators

[object Object]